Skip to main content
. 2015 Oct 12;35(25):3303–3313. doi: 10.1038/onc.2015.391

Figure 8.

Figure 8

Schematic signaling pathway for mSH3BGRL or hSH3BGRL mutant-mediated metastasis. mSH3BGRL-alike hSH3BGRL mutants or with modification activate the downstream FAK/Src complex and the further AKT and Erk signals via c-Src kinase, and selectively blocking hyperactive c-Src by specific antagonists, including siRNAs could effectively delay tumor cell metastasis.